Mangoceuticals (MGRX) Non Operating Income (2023 - 2026)

Mangoceuticals has disclosed Non Operating Income across 4 years of filings, most recently posting -$279891.0 for Q2 2026.

• In Q2 2026, Non Operating Income fell 89.98% year-over-year to -$279891.0; the TTM figure through Jun 2026 stood at -$3.0 million (down 228.73% YoY), while the FY2025 annual figure was -$2.6 million, down 255.14% from the prior year.
• Non Operating Income came in at -$279891.0 for Q2 2026 at Mangoceuticals, down from -$276815.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $8233.0 in Q2 2023 to a low of -$2.4 million in Q4 2025.
• Average Non Operating Income over 4 years is -$379398.8, with a median of -$241620.0 recorded in 2024.
• Year-over-year, Non Operating Income plunged 2804.7% in 2024 and soared 68.61% in 2025.
• Over 4 years, Non Operating Income stood at $8233.0 in 2023, then plunged by 3390.84% to -$270935.0 in 2024, then sank by 786.42% to -$2.4 million in 2025, then surged by 88.35% to -$279891.0 in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were -$279891.0 in Q2 2026, -$276815.0 in Q1 2026, and -$2.4 million in Q4 2025.